Efficacy and Safety of Once‐weekly Exenatide after Switching from Twice‐daily Exenatide in Patients with Type 2 Diabetes

Yuusuke Watanabe,Yoshifumi Saisho,Jun Inaishi,Kinsei Kou,Akira Yamauchi,Yasuhiko Kanazawa,Yoshiaki Okubo,Mikiya Tokui,Takatoshi Imai,Rie Murakami,Tami Tsuchiya,Hironobu Sasaki,Tatsuhiro Masaoka,Junichiro Irie,Shu Meguro, Hiroshi Itoh

Journal of Diabetes Investigation（2019）

引用 6|浏览34

暂无评分

摘要

To evaluate the efficacy and safety of once‐weekly (q.w.) extended‐release exenatide after switching from twice‐daily (b.i.d.) exenatide in patients with type 2 diabetes.

查看译文

关键词

Glucagon-like peptide-1 receptor agonist,Treatment satisfaction,Type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要